| Campo DC | Valor | Idioma |
|---|
| dc.contributor.author | Rosa, Isabella Naves Rosa | - |
| dc.contributor.author | Soares, Alexandre Anderson de Sousa Munhoz | - |
| dc.contributor.author | Rodrigues, Marcelo Palmeira | - |
| dc.contributor.author | Naves, Luciana Ansaneli | - |
| dc.date.accessioned | 2021-04-20T18:35:01Z | - |
| dc.date.available | 2021-04-20T18:35:01Z | - |
| dc.date.issued | 2021-03-17 | - |
| dc.identifier.citation | ROSA, Isabella Naves et al. Classic cardiovascular risk factors improve in very elderly hypopituitary patients treated on standard hormone replacement in long term follow-up. Clinical Diabetes and Endocrinology, v. 7, art. n. 6, 2021. DOI: https://doi.org/10.1186/s40842-021-00119-6. Disponível em: https://clindiabetesendo.biomedcentral.com/articles/10.1186/s40842-021-00119-6. Acesso em: 20 abr. 2021. | pt_BR |
| dc.identifier.uri | https://repositorio.unb.br/handle/10482/40605 | - |
| dc.language.iso | Inglês | pt_BR |
| dc.publisher | BMC | pt_BR |
| dc.rights | Acesso Aberto | pt_BR |
| dc.title | Classic cardiovascular risk factors improve in very elderly hypopituitary patients treated on standard hormone replacement in long term follow-up | pt_BR |
| dc.type | Artigo | pt_BR |
| dc.subject.keyword | Fatores de risco | pt_BR |
| dc.subject.keyword | Sistema cardiovascular - doenças | pt_BR |
| dc.subject.keyword | Idosos | pt_BR |
| dc.rights.license | © The Author(s). 2021 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data. | pt_BR |
| dc.description.abstract1 | Background -
Hypopituitarism in the elderly population is an underdiagnosed condition and may increase comorbidities related to glucose metabolism, dyslipidemia, and cardiovascular risk factors. Optimization of hormone replacement that considers alterations in clearance rates of hormones, interaction with other medications, and evaluation of the risk-benefit ratio of treatment is a big challenge for clinical practice.
Objectives -
This study aimed to evaluate classic cardiovascular risk factors in hypopituitary septuagenarians and octagenarians by diagnosis and after long-term hormone replacement.
Methods -
This is a retrospective observational study, with patients recruited and selected from a registry in a tertiary medical center. We included patients aged 70–99 years with hypopituitarism, evaluated hormonal and biochemical parameters, and cardiovascular risk scores were calculated by diagnosis and compared after long-term follow-up. All patients gave informed consent. Patient data were compared to a sex and age-matched control group, with long-term geriatric follow-up, without endocrine diseases.
Results - Thirty-five patients were included, 16 patients aged 70–75 years (72.61), 12 patients 76–80 years (72.28), 7 patients 81–99 years (89.28). Pituitary macroadenomas were the main cause of hypopituitarism, mean maximal diameter 3.4 cm (2.9–4.3), and invasive craniopharyngiomas. At the moment of diagnosis, most patients were overweight, and abdominal adiposity was observed in 76.9% of women and 36.4% of men, primarily in octagenarians and nonagenarians. Comorbidities were frequent; 85.7% presented hypertension, 37.1% diabetes, 53.1% low HDL, 51.5% hypertriglyceridemia. Most patients presented more than two combined pituitary deficiencies; hypogonadism in 88.6%, central hypothyroidism in 82.9%, GH deficiency in 65.7%, and adrenal insufficiency in 25.7%. Analysis of cardiovascular risk prediction in the total cohort showed that 57.1% of patients presented a reduction in the General Cardiovascular Disease (CVD) Risk Prediction Score and 45.7% in atherosclerotic CVD risk estimated by ACC/AHA 2013 Pooled Cohort Equation, despite being submitted to conventional hormone replacement, during the mean follow-up of 14.5 years. This reduction was not observed in the control group.
Discussion and conclusion -
In this study, aged hypopituitary patients presented a reduction in estimated general CVD risk during long-term follow-up, despite replacement with corticosteroids, levothyroxine, or gonadal steroids. Early diagnosis and treatment of hypopituitarism in the elderly remain challenging. Larger studies should be performed to assess the risk-benefit ratio of hormone replacement on the metabolic profile in septuagenarian and octogenarian patients. | pt_BR |
| dc.identifier.orcid | https://orcid.org/0000-0002-3363-3803 | pt_BR |
| dc.description.unidade | Faculdade de Medicina (FMD) | - |
| Aparece nas coleções: | Artigos publicados em periódicos e afins
|
